Cartmell J - Search Results

1

The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing.

Cartmell J, Monn JA, Schoepp DD. Cartmell J, et al. Eur J Pharmacol. 2000 Jul 21;400(2-3):221-4. doi: 10.1016/s0014-2999(00)00423-4. Eur J Pharmacol. 2000. PMID: 10988337

2

The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.

Cartmell J, Monn JA, Schoepp DD. Cartmell J, et al. J Pharmacol Exp Ther. 1999 Oct;291(1):161-70. J Pharmacol Exp Ther. 1999. PMID: 10490900

3

Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268.

Cartmell J, Monn JA, Schoepp DD. Cartmell J, et al. Naunyn Schmiedebergs Arch Pharmacol. 2000 Jan;361(1):39-46. doi: 10.1007/s002109900151. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 10651145

4

Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine.

Cartmell J, Monn JA, Schoepp DD. Cartmell J, et al. Psychopharmacology (Berl). 2000 Mar;148(4):423-9. doi: 10.1007/s002130050072. Psychopharmacology (Berl). 2000. PMID: 10928316

5

Regulation of neurotransmitter release by metabotropic glutamate receptors.

Cartmell J, Schoepp DD. Cartmell J, et al. J Neurochem. 2000 Sep;75(3):889-907. doi: 10.1046/j.1471-4159.2000.0750889.x. J Neurochem. 2000. PMID: 10936169 Free article. Review.

6

The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.

Cartmell J, Perry KW, Salhoff CR, Monn JA, Schoepp DD. Cartmell J, et al. J Neurochem. 2000 Sep;75(3):1147-54. doi: 10.1046/j.1471-4159.2000.0751147.x. J Neurochem. 2000. PMID: 10936197 Free article.

7

Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.

Cartmell J, Salhoff CR, Perry KW, Monn JA, Schoepp DD. Cartmell J, et al. Brain Res. 2000 Dec 29;887(2):378-84. doi: 10.1016/s0006-8993(00)03067-5. Brain Res. 2000. PMID: 11134627

8

Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.

Cartmell J, Perry KW, Salhoff CR, Monn JA, Schoepp DD. Cartmell J, et al. Neuropharmacology. 2001 Jun;40(7):847-55. doi: 10.1016/s0028-3908(01)00034-x. Neuropharmacology. 2001. PMID: 11378155

9

Potent desensitization of human P2X3 receptors by diadenosine polyphosphates.

McDonald HA, Chu KL, Bianchi BR, McKenna DG, Briggs CA, Burgard EC, Lynch KJ, Faltynek C, Cartmell J, Jarvis MF. McDonald HA, et al. Among authors: cartmell j. Eur J Pharmacol. 2002 Jan 25;435(2-3):135-42. doi: 10.1016/s0014-2999(01)01568-0. Eur J Pharmacol. 2002. PMID: 11821019

10

In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.

Schaffhauser H, Richards JG, Cartmell J, Chaboz S, Kemp JA, Klingelschmidt A, Messer J, Stadler H, Woltering T, Mutel V. Schaffhauser H, et al. Among authors: cartmell j. Mol Pharmacol. 1998 Feb;53(2):228-33. Mol Pharmacol. 1998. PMID: 9463480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page